NRIX vs NTHI

Nurix Therapeutics, Inc. vs NeOnc Technologies Holdings, In — Valuation Comparison 2026

NRIX

Biotechnology
Nurix Therapeutics, Inc.
Quality
6.4
out of 10
Value Trap
12
SAFE
Price
$17.67
Last close
Models
9/13
Active
VS

NTHI

Biotechnology
NeOnc Technologies Holdings, In
Quality
3.7
out of 10
Value Trap
Price
$4.79
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType NRIX Fair ValueNRIX Upside NTHI Fair ValueNTHI Upside
Bayesian DCF Intrinsic $4.91 -72.2% $0.70 -85.4%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $4.75 -73.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $2.71 -50.2%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for NRIX vs NTHI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NRIX vs NTHI — Which Stock Is More Undervalued?

NRIX scores higher with a 6.4/10 quality rating vs NTHI's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Nurix Therapeutics, Inc. (NRIX) and NeOnc Technologies Holdings, In (NTHI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NRIX currently trades at $17.67 with a QOC of 6.4/10, while NTHI trades at $4.79 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).